BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 15282235)

  • 21. Local antiseptics versus antibiotics in topical therapy--the emergence of microbial resistance.
    Kessler HJ
    Mykosen; 1980 Jun; 23(6):285-9. PubMed ID: 7421882
    [No Abstract]   [Full Text] [Related]  

  • 22. Reduced triclosan susceptibility in methicillin-resistant Staphylococcus epidermidis.
    Schmid MB; Kaplan N
    Antimicrob Agents Chemother; 2004 Apr; 48(4):1397-9. PubMed ID: 15047551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Whither triclosan?
    Russell AD
    J Antimicrob Chemother; 2004 May; 53(5):693-5. PubMed ID: 15073159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of the antiseptic- and disinfectant-resistance genes qacA, qacB, and qacC in methicillin-resistant Staphylococcus aureus isolated in a Tokyo hospital.
    Sekiguchi J; Hama T; Fujino T; Araake M; Irie A; Saruta K; Konosaki H; Nishimura H; Kawano A; Kudo K; Kondo T; Sasazuki T; Kuratsuji T; Yoshikura H; Kirikae T
    Jpn J Infect Dis; 2004 Dec; 57(6):288-91. PubMed ID: 15623960
    [No Abstract]   [Full Text] [Related]  

  • 25. Elimination of a community-acquired methicillin-resistant Staphylococcus aureus infection in a nurse with atopic dermatitis.
    Roesch A; Linde HJ; Landthaler M; Vogt T
    Arch Dermatol; 2005 Dec; 141(12):1520-2. PubMed ID: 16365252
    [No Abstract]   [Full Text] [Related]  

  • 26. Susceptibility of compound 48/80-sensitized Pseudomonas aeruginosa to the hydrophobic biocide triclosan.
    Ellison ML; Roberts AL; Champlin FR
    FEMS Microbiol Lett; 2007 Apr; 269(2):295-300. PubMed ID: 17263842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between antibiotic and biocide resistance in mesophilic and psychrotrophic Pseudomonas spp. isolated from slaughterhouse surfaces throughout meat chain production.
    Lavilla Lerma L; Benomar N; Casado Muñoz Mdel C; Gálvez A; Abriouel H
    Food Microbiol; 2015 Oct; 51():33-44. PubMed ID: 26187825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Triclosan resistance in methicillin-resistant Staphylococcus aureus (MRSA).
    Brenwald NP; Fraise AP
    J Hosp Infect; 2003 Oct; 55(2):141-4. PubMed ID: 14529640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of growth media on the sensitivity of Staphylococcus aureus and Pseudomonas aeruginosa to cationic biocides.
    Brill F; Goroncy-Bermes P; Sand W
    Int J Hyg Environ Health; 2006 Jan; 209(1):89-95. PubMed ID: 16373206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Relevance of Type II Fatty Acid Synthesis Bypass in Staphylococcus aureus.
    Gloux K; Guillemet M; Soler C; Morvan C; Halpern D; Pourcel C; Vu Thien H; Lamberet G; Gruss A
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28193654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Resistance of Staphylococcus aureus strains isolated from patients with wound infections to basic disinfectants and antibiotics].
    Mel'nikova MIa; Reznichenko AP
    Gig Sanit; 1982 Jul; (7):72-4. PubMed ID: 7129126
    [No Abstract]   [Full Text] [Related]  

  • 32. Sustained antibacterial activity from triclosan-loaded nanostructured mesoporous silicon.
    Wang M; Coffer JL; Dorraj K; Hartman PS; Loni A; Canham LT
    Mol Pharm; 2010 Dec; 7(6):2232-9. PubMed ID: 20973523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outer membrane permeability for nonpolar antimicrobial agents underlies extreme susceptibility of Pasteurella multocida to the hydrophobic biocide triclosan.
    Ellison ML; Champlin FR
    Vet Microbiol; 2007 Oct; 124(3-4):310-8. PubMed ID: 17560745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of triclosan on uropathogen susceptibility to clinically relevant antibiotics.
    Wignall GR; Goneau LW; Chew BH; Denstedt JD; Cadieux PA
    J Endourol; 2008 Oct; 22(10):2349-56. PubMed ID: 18937596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microarray analysis of toxicogenomic effects of triclosan on Staphylococcus aureus.
    Jang HJ; Chang MW; Toghrol F; Bentley WE
    Appl Microbiol Biotechnol; 2008 Mar; 78(4):695-707. PubMed ID: 18210102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resistance to disinfectants in epidemiologically defined clinical isolates of Acinetobacter baumannii.
    Wisplinghoff H; Schmitt R; Wöhrmann A; Stefanik D; Seifert H
    J Hosp Infect; 2007 Jun; 66(2):174-81. PubMed ID: 17498843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasmids and bacterial resistance to biocides.
    Russell AD
    J Appl Microbiol; 1997 Aug; 83(2):155-65. PubMed ID: 9281819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and evaluation of amphiphilic cationic quinine-derived for antibacterial activity against methicillin-resistant Staphylococcus aureus.
    Lv J; Qian Y; Liu T; Wang Y
    Bioorg Med Chem Lett; 2007 Aug; 17(15):4102-6. PubMed ID: 17570664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of the source of susceptibility-test agar on the in vitro activity of antibiotics against Staphylococcus aureus].
    Ito Y; Yoshida T; Fujita S; Matsubara F
    Rinsho Byori; 1989 Jan; 37(1):84-8. PubMed ID: 2724585
    [No Abstract]   [Full Text] [Related]  

  • 40. Discovery of 4-Pyridone derivatives as specific inhibitors of enoyl-acyl carrier protein reductase (FabI) with antibacterial activity against Staphylococcus aureus.
    Takahata S; Iida M; Yoshida T; Kumura K; Kitagawa H; Hoshiko S
    J Antibiot (Tokyo); 2007 Feb; 60(2):123-8. PubMed ID: 17420562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.